GLYCERYL PALMITOSTEARATE
Substance profile for UNII GSY51O183C, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Substance Identity#
- UNII
- GSY51O183C
- Preferred term
- GLYCERYL PALMITOSTEARATE
- Registry number
- 8067-32-1
- EC number
- 232-514-8
- Ingredient type
- INGREDIENT SUBSTANCE
Chemical And Database Identifiers#
- RxCUI
- 1423683
- PubChem
- 0
- INN ID
- 0
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| RxNorm | 1423683 |  mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1423683 |
| FDA Substance Registration System | GSY51O183C |  precision.fda.gov/uniisearch/srs/unii/GSY51O183C |
| European Community number | 232-514-8 |  commonchemistry.cas.org/results?q=232-514-8 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GLYCERYL PALMITOSTEARATE | INACTIVE INGREDIENT | GSY51O183C | These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN. XIFAXAN® (rifaximin) Tablets Initial U.S. Approval: 2004 To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 1 | |
| GLYCERYL PALMITOSTEARATE | INACTIVE INGREDIENT | GSY51O183C | XIFAXAN (RIFAXIMIN) TABLET [SALIX PHARMACEUTICALS, INC.] | 23 | |
| GLYCERYL PALMITOSTEARATE | INACTIVE INGREDIENT | GSY51O183C | XIFAXAN (RIFAXIMIN) TABLET [CARILION MATERIALS MANAGEMENT] | 2 |
Inactive Ingredient Database#
| Ingredient | UNII | CAS | Dosage form | Route | Potency | Maximum daily exposure |
|---|---|---|---|---|---|---|
| GLYCERYL PALMITOSTEARATE | GSY51O183C | 8067321 | INJECTION | INTRADERMAL | 16 mg | |
| GLYCERYL PALMITOSTEARATE | GSY51O183C | 8067321 | SUSPENSION | ORAL | 150 mg/5ml | |
| GLYCERYL PALMITOSTEARATE | GSY51O183C | 8067321 | TABLET | ORAL | 149 mg | |
| GLYCERYL PALMITOSTEARATE | GSY51O183C | 8067321 | AEROSOL | TOPICAL | 2.55 %w/w | |
| GLYCERYL PALMITOSTEARATE | GSY51O183C | 8067321 | CREAM | TOPICAL | 2.78 %w/w | |
| GLYCERYL PALMITOSTEARATE | GSY51O183C | 8067321 | EMULSION | TOPICAL | 2.55 %w/w |